Global Synthetic Biology Market By Overview
Synthetic Biology Market was valued at US$ 14.5 billion in 2024 and is projected to grow at a CAGR of 24.2% to reach US$ 126.9 billion by 2034.
Synthetic biology is the combination of science and engineering which is used in testing, construction, and designing of novel artificial organisms, cells etc. through combination of domains such as molecular biology, genetic engineering and evolutionary biology to modify or redesign existing natural biological systems. It integrates chemical synthesis of DNA with growing knowledge of genomics to empower researchers to quickly manufacture catalogued DNA sequences and fabricate them into new genomes that can be used in the production of advanced bio fuels, bio-products, renewable chemicals, bio-based specialty chemicals and in the health care sector as well.
Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.
Global Synthetic Biology Market By Dynamics
Increasing involvement of government bodies
Increasing involvement of government bodies, research institutes, large-scale organizations and declining cost of DNA sequencing & synthesizing synthetic biology research activities, rising R&D funding drives the growth of the global synthetic biology market. Further, the increasing need for food owing to the increasing population and demand for synthetic genes and synthetic cells fosters the growth of global synthetic biology market. Moreover, advancement in genome engineering such as CRISPR and DNA synthesis technologies also enhances the growth of global synthetic biology market. However, bio-safety & bio-security, ethical issues related to misuse of synthetic biology and possibilities of accidental release of pathogens into free atmosphere hamper the growth of global synthetic biology market. In addition, complicated and irregular construction and testing process of biological systems restrains the growth of synthetic biology market.
Global Synthetic Biology Market By Segmentation
This report segments Global synthetic market has been segmented on the basis of product type, application and region. On the basis of product type, the global synthetic biology market is segmented into core products (synthetic DNA, synthetic cells, synthetic genes and synthetic clones etc.) and enabling products (DNA synthesis and oligonucleotide synthesis). On the basis of technology, the global synthetic biology market is segmented into genome engineering, DNA sequencing, bioinformatics, biological components and integrated systems. On the basis of application, the global synthetic biology market is segmented into healthcare, agriculture, chemicals and others.
Regional Insights:
Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.
On the basis of region, the global synthetic biology market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
North America holds the maximum share in the global synthetic biology market owing to the presence of advanced healthcare infrastructure, government investments, and major players in countries in this region. Asia Pacific and Europe on the basis of region are expected to hold significant shares in the growth of global synthetic biology market attributed to government participation and the increase in the funding for the development of synthetic biology over the forecast period.
Report Scope:
|
Attribute |
Details |
|
Market Size 2024 |
US$ 14.5 billion |
|
Projected Market Size 2034 |
US$ 126.9 billion |
|
CAGR Growth Rate |
24.2% |
|
Base year for estimation |
2023 |
|
Forecast period |
2024 – 2034 |
|
Market representation |
Revenue in USD Billion & CAGR from 2024 to 2034 |
|
Market Segmentation |
By Product type - Core Products (Synthetic DNA, Synthetic Cells, Synthetic Genes And Synthetic Clones Etc.) And Enabling Products (DNA Synthesis And Oligonucleotide Synthesis By Technology- Genome Engineering, DNA Sequencing, Bioinformatics, Biological Components And Integrated Systems By Application– Healthcare, Agriculture, Chemicals And Others |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034. For the purpose of this study, has segmented the Synthetic Biology Market report based on Product Type, Technology, Application and region:
Synthetic Biology Market, By Region:
- North America
- Middle East & Africa
- Middle East & Africa Synthetic biology Market, By Product type
- Middle East & Africa Synthetic biology Market, By Technology
- Middle East & Africa Synthetic biology Market, By Application
- Middle East & Africa Synthetic biology Market, By Country
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Latin America Synthetic biology Market, By Product type
- Latin America Synthetic biology Market, By Technology
- Latin America Synthetic biology Market, By Application
- Latin America Synthetic biology Market, By Country
- Brazil
- Mexico
- Rest of Latin America
- Asia Pacific
- Asia Pacific Synthetic biology Market, By Product type
- Asia Pacific Synthetic biology Market, By Technology
- Asia Pacific Synthetic biology Market, By Application
- Asia Pacific Synthetic biology Market, By Country
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Europe
- Europe Synthetic biology Market, By Product type
- Europe Synthetic biology Market, By Technology
- Europe Synthetic biology Market, By Application
- Europe Synthetic biology Market, By Country
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- North America Synthetic biology Market, By Product type
- North America Synthetic biology Market, By Technology
- North America Synthetic biology Market, By Application
- North America Synthetic biology Market, By Country
- U.S.
- Canada
- Middle East & Africa
Global Synthetic Biology Market By Key Players
Key players operating in the global synthetic biology market includes Thermo Fischer Scientific, GenScript, Biosearch Technologies, Integrated DNA technologies, Eurofins Scientific, Inc., Origene technologies, Scientific genomics Inc., Editas Medicine, Inc., Pareto Biotechnologies and Syntrox Inc.
Key features of the study:
Prophecy Market Insights provides detailed analysis on synthetic biology market in our report- Global Synthetic biology Market by product type, application, and region. The report provides market size (US$ Mn) and compounded annual growth rate (%) for the forecast period: 2019 – 2029, considering 2018 as the actual year. The report also contains in-depth analysis about market drivers, restraints, opportunities, new product launches, product approval, ongoing trends, customers demand, and regional outlook. The report delivers competitive analysis about leading players in the global synthetic biology market based on various parameters such as company overview, product portfolio, regional presence, financial performance, distribution strategies, key developments, marketing strategies, and future plans. The analysis from the report would acquaint the marketers and management authorities of companies to make the appropriate decision with respect to their future product launch, ongoing trends, market expansion, and marketing tactics used overall the globe. Various strategy matrices include in the report are PEST analysis, PORTER’s five forces analysis, and opportunity map analysis to analyze the synthetic biology market.
Global Synthetic Biology Market By Key Issues Addressed
Recent Development:
- In January 2024, Rice University launched the Rice Synthetic Biology Institute, which aims to catalyze collaborative research in synthetic biology and its translation into technologies that benefit society. The Rice Synthetic Biology Institute demonstrates how everyone benefits when the top minds in natural sciences and engineering collaborate at a leading research university.
- In January 2024, Asimov, synthetic biology company, launched its new LV edge packaging system, claiming to improve the cost efficiency and reduce the supply chain risk of lentiviral production. The system minimizes GMP plasmid cost, process complexity, and supply chain risk by integrating viral genes into the host cell.
Global Synthetic Biology Market By Company Profile
- Thermo Fischer Scientific
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- GenScript
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
-
- Biosearch Technologies
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
-
- Integrated DNA technologies
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
-
- Eurofins Scientific, Inc.
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
-
- Origene technologies
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
-
- Scientific genomics Inc.
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
-
- Editas Medicine, Inc.
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
-
- Pareto Biotechnologies
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
-
- Syntrox Inc
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
-
-
Global Synthetic Biology Market By Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Preview
- Executive Summary
- Key Findings—Global Outlook for Synthetic Biology Strategies
- Key Questions this Study will Answer
- Market Snippet, By Product Type
- Market Snippet, By Application
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Market Segmentation, By Product type, 2020 – 2030, (US$ Mn)
- Core Product
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Enabling Product
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Enabled Product
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Core Product
- Market Segmentation, By Application, 2020 – 2030, (US$ Mn)
- Oncology
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Healthcare
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Agriculture
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Chemicals
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Others
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Oncology
- Global Market, By Region, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Product type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Product type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Product type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Product type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
-
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Product type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
- Thermo Fischer Scientific
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
-
- GenScript
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
-
- Biosearch Technologies
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
-
- Integrated DNA technologies
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
-
- Eurofins Scientific, Inc.
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
-
- Origene technologies
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
-
- Scientific genomics Inc.
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
-
- Editas Medicine, Inc.
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
-
- Pareto Biotechnologies
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
-
- Syntrox Inc
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
-
- Thermo Fischer Scientific
The Last Word
-
- Future Impact
- About Us
- Contact
FAQs
Synthetic Biology market is segmented based on product type, application and region. On the basis of product type, the global synthetic biology market is segmented into core products (synthetic DNA, synthetic cells, synthetic genes and synthetic clones etc.) and enabling products (DNA synthesis and oligonucleotide synthesis).
Increasing involvement of government bodies, research institutes, large-scale organizations and declining cost of DNA sequencing & synthesizing synthetic biology research activities, rising R&D funding drives the growth of the global synthetic biology market.
North America holds the maximum share in the global synthetic biology market owing to the presence of advanced healthcare infrastructure, government investments, and major players in countries in this region.
Key players operating in the synthetic biology market includes Thermo Fischer Scientific, GenScript, Biosearch Technologies, Integrated DNA technologies, Eurofins Scientific, Inc., Origene technologies, Scientific genomics Inc., Editas Medicine, Inc., Pareto Biotechnologies and Syntrox Inc.